SEROTONIN REGULATION OF BASAL GANGLIA NEUROPEPTIDES
SEROTONIN REGULATION OF BASAL GANGLIA NEUROPEPTIDES
批准号:
2268505
负责人:
PAUL D WALKER
金额:
$12.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 1997-06-30
关键词:
afferent nerve basal ganglia developmental genetics developmental neurobiology dopamine enkephalins experimental brain lesion gene induction /repression glutamate receptor glutamates high performance liquid chromatography in situ hybridization laboratory rat neural transmission neuropeptides neuropharmacology newborn animals northern blottings peptide hormone biosynthesis serotonin serotonin inhibitor serotonin receptor tachykinin
中文摘要
这项研究将确定5-羟色胺传递在
基底节神经肽基因表达的调控。
具体地说,我们将检验如下假设:5-羟色胺传递
提供对神经肽nMRA表达的调节控制
基底节通过多种受体亚型。虽然这项规定
可能仅在正常情况下对基因表达进行轻微调整
在成人大脑的状况下,5-羟色胺可能会产生更大的影响
在发育过程中,对多巴胺耗竭的反应,或在
谷氨酸诱导的兴奋性毒性损伤。以下具体目标将
确定:
1.5-羟色胺受体介导的基因表达调控
正常成人基底节。多种5-羟色胺受体亚型可能
差异影响基底节的基因表达。北方
将利用分析和原位杂交方法来确定
哪些5-羟色胺受体与转录调控有关
前速激肽原和前脑啡肽原基因在纹状体中表达。
2.5-羟色胺对大鼠基底神经节基因表达的影响
发展。传入前脑的5-羟色胺在
发育,并已被假设在大脑中发挥形态发生作用
成熟。在胚胎和出生后早期,5-羟色胺
传播将被改变,特定的受体亚型将被
发现影响神经肽基因表达发展的因素
基底节的模式。
3.5-羟色胺对基底神经节基因表达的影响
多巴胺传递。5-羟色胺可能增加其对基础状态的影响
多巴胺改变对神经节基因表达的影响
神经传递。因此,实验将确定
5-羟色胺及其受体在神经肽基因表达调控中的作用
在对新生儿和新生儿进行多巴胺神经传递操作后
成年人的大脑。
4.谷氨酸过程中影响基因表达的5-羟色胺机制
神经传递与基底节的兴奋毒性损伤。5-羟色胺
可能调节谷氨酸兴奋性神经递质在脑内的作用
基底节以及介导谷氨酸受体诱导
兴奋性毒性。实验将确定5-羟色胺如何促进
异常时基底节基因表达的调节
谷氨酸受体刺激。
这些研究的完成将增加我们对如何
5-羟色胺传递影响正常人群的基因表达模式
发育中的和成年的基底节;以及对
多巴胺和谷氨酸的神经传递。这样的信息将会增加
我们对5-羟色胺作为基底神经节主要传入调节因子的认识
作用并导致以5-羟色胺为基础的疗法的发展
治疗基底节疾病。
英文摘要
This research will determine the role of serotonin transmission in the
regulation of neuropeptide gene expression in the basal ganglia.
Specifically, we will test hypothesis that: Serotonin transmission
provides regulatory control over neuropeptide nMRA expression within the
basal ganglia via multiple receptor subtypes. Although this regulation
may only provide slight adjustments to gene expression under normal
conditions in the adult brain, serotonin may exert larger influences
during development, in response to dopamine depletion, or during
glutamate-induced excitotoxic damage. The following specific aims will
determine:
1. Serotonin Receptor-Mediated Regulation of Gene Expression in the
Normal Adult Basal Ganglia. Multiple serotonin receptors subtypes may
differentially influence gene expression in the basal ganglia. Northern
analysis and in situ hybridization methods will be utilized to determine
which serotonin receptors are linked to transcriptional regulation of
preprotachykinin and preproenkephalin genes expressed in the striatum.
2. Serotonin Influences on Basal Ganglia Gene Expression during
Development. Serotonin afferent to the forebrain appear early during
development and have been postulated to play a morphogenic role in brain
maturation. During embryonic and early postnatal time periods, serotonin
transmission will be altered and specific receptors subtypes will be
identified that influence the development of neuropeptide gene expression
patterns in the basal ganglia.
3. Serotonin Influences on Basal Ganglia Gene Expression during Altered
Dopamine Transmission. Serotonin may increase its influence on basal
ganglia gene expression in response to altered dopamine
neurotransmission. Therefore, experiments will determine the role of
serotonin and its receptors in regulating neuropeptide gene expression
following manipulation of dopamine neurotransmission in both neonatal and
adult brains.
4. Serotonin Mechanisms That Affect Gene Expression during Glutamate
Neurotransmission and Excitotoxic Damage of the Basal Ganglia. Serotonin
may modulate the effects of glutamate excitatory neurotransmission in the
basal ganglia, as well as mediate glutamate receptor induced
excitotoxicity. Experiments will determine how serotonin contributes to
the regulation of basal ganglia gene expression following abnormal
glutamate receptor stimulation.
Completion of these studies will increase our understanding of how
serotonin transmission influences gene expression patterns in the normal
developing and adult basal ganglia; as well as in response to changes in
dopamine and glutamate neurotransmission. Such information will increase
our awareness of serotonin as a major afferent regulator of basal ganglia
function and lead to the development of serotonin-based therapies to
treat basal ganglia disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SEROTONIN CONTROL MECHANISMS OF BASAL GANGLIA FUNCTION
-
批准号:6331733
-
项目类别:
-
资助金额:$25.07万
-
财政年份:2001
-
负责人:PAUL D WALKER
-
依托单位:
SEROTONIN CONTROL MECHANISMS OF BASAL GANGLIA FUNCTION
-
批准号:6540137
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2001
-
负责人:PAUL D WALKER
-
依托单位:
SEROTONIN CONTROL MECHANISMS OF BASAL GANGLIA FUNCTION
-
批准号:6639587
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2001
-
负责人:PAUL D WALKER
-
依托单位:
SEROTONIN CONTROL MECHANISMS OF BASAL GANGLIA FUNCTION
-
批准号:6729123
-
项目类别:
-
资助金额:$26.08万
-
财政年份:2001
-
负责人:PAUL D WALKER
-
依托单位:
SEROTONIN REGULATION OF BASAL GANGLIA NEUROPEPTIDES
-
批准号:2268507
-
项目类别:
-
资助金额:$12.89万
-
财政年份:1994
-
负责人:PAUL D WALKER
-
依托单位:
SEROTONIN REGULATION OF BASAL GANGLIA NEUROPEPTIDES
-
批准号:2268506
-
项目类别:
-
资助金额:$12.41万
-
财政年份:1994
-
负责人:PAUL D WALKER
-
依托单位:
海外基金